ACE2 and COVID-19: SARS-CoV-2 receptor, ACE2, which plays a crucial role in the relationship between COVID-19 and hyperglycemia, is expressed in both exocrine glands and pancreas islets; therefore, pancreatic endocrine damage is expected (20).